In vitro antimicrobial activity of rifaximin against enteropathogens causing traveler's diarrhea
- Joaquim Ruiz(corresponding author),
- Laura Mensa,
- Cristina O'Callaghan,
- ,
- Ana González,
- Jordi Vila
- ,
- Departament de Microbiologia,
- Hospital Clínic – Universitat de Barcelona
Research Output:
Contribution to journal
Article
Peer-reviewPublication Information
Output type
Research Output:
Contribution to journal
Article
Peer-reviewOriginal language
EnglishPages from-to (Number of pages)
Pages 473-475 (3 pages)Journal (Volume, Issue Number)
Diagnostic Microbiology and Infectious Disease (Volume 59, Issue 4)Publication milestones
- Published - 12/2007
Publication status
Published - 12/2007
ISSN
0732-8893Publication IDs
- Scopus: 36549015767
- PubMed: 17889485
Abstract
The in vitro activity of rifaximin against 84 diarrheagenic Escherichia coli and 11 Shigella sonnei causing traveler's diarrhea was evaluated. The MIC of rifaximin ranged between <0.007 and 32 mg/L; other agents tested had an MIC of >256 mg/L in most cases. The results showed the potential use of rifaximin to treat these infections.
Funding Details
Dr. Ruiz is a recipient from grant CP05/0130 from Fondo de Investigaciones Sanitarias. JV research is supported by grants FIS05/0068 from Fondo de Investigaciones Sanitarias and SGR050444 from the Departament d'Universitats, Recerca i Societat de la Informació de la Generalitat de Catalunya.
This work was also partially supported by project RICET-C03/04 and by Laboratorios BamaGeve. The Centro the Salud Internacional is also supported by the RCESP.
FundersFunding numbers
Departament d'Universitats, Recerca i Societat de la Informació de la Generalitat de Catalunya
-Fondo de Investigaciones Sanitarias
SGR050444
Laboratorios BamaGeve
-RCESP
-Publication metrics
Metrics
PlumX, opens in new tab
Citations
33
Captures
33
Sustainable Development Goals
SDG 3 Good Health and Well